Daron Evans, CEO of Specialty Renal Product at Nephros, holds 203.35K shares in Rezolute (Ticker: RZLT), holds 160.42K shares in Nephros (Ticker: NEPH). Most recently, Daron Evans Bought ― shares of Rezolute on Jun 14, 2024 for an estimated value of 161.20K.